JP2021513547A5 - - Google Patents
Info
- Publication number
- JP2021513547A5 JP2021513547A5 JP2020543286A JP2020543286A JP2021513547A5 JP 2021513547 A5 JP2021513547 A5 JP 2021513547A5 JP 2020543286 A JP2020543286 A JP 2020543286A JP 2020543286 A JP2020543286 A JP 2020543286A JP 2021513547 A5 JP2021513547 A5 JP 2021513547A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- alkyl
- halo
- cyano
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862630775P | 2018-02-14 | 2018-02-14 | |
| US62/630,775 | 2018-02-14 | ||
| US201862631442P | 2018-02-15 | 2018-02-15 | |
| US62/631,442 | 2018-02-15 | ||
| PCT/US2019/017881 WO2019160980A1 (en) | 2018-02-14 | 2019-02-13 | Derivatives of sobetirome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021513547A JP2021513547A (ja) | 2021-05-27 |
| JP2021513547A5 true JP2021513547A5 (enExample) | 2022-02-17 |
Family
ID=67619583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543286A Pending JP2021513547A (ja) | 2018-02-14 | 2019-02-13 | ソベチロムの誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11578032B2 (enExample) |
| EP (1) | EP3752001A4 (enExample) |
| JP (1) | JP2021513547A (enExample) |
| KR (1) | KR20200120928A (enExample) |
| CN (1) | CN111818798A (enExample) |
| AU (1) | AU2019222709A1 (enExample) |
| BR (1) | BR112020016599A2 (enExample) |
| CA (1) | CA3091021A1 (enExample) |
| IL (1) | IL276592B2 (enExample) |
| MX (1) | MX2020008498A (enExample) |
| WO (1) | WO2019160980A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019397067A1 (en) | 2018-12-12 | 2021-07-22 | Autobahn Therapeutics, Inc. | Novel thyromimetics |
| WO2020180624A1 (en) | 2019-03-01 | 2020-09-10 | Autobahn Therapeutics, Inc. | Novel thyromimetics |
| US12466781B2 (en) | 2019-11-29 | 2025-11-11 | Autobahn Therapeutics, Inc. | Thyromimetics |
| US20230348364A1 (en) * | 2020-06-03 | 2023-11-02 | Autobahn Therapeutics, Inc. | Isotopic thyromimetic compounds |
| WO2021257851A1 (en) | 2020-06-17 | 2021-12-23 | Autobahn Therapeutics, Inc. | Thyromimetics |
| US20230242473A1 (en) * | 2020-06-17 | 2023-08-03 | Autobahn Therapeutics, Inc. | Thyromimetics |
| US12590072B2 (en) | 2020-06-17 | 2026-03-31 | Autobahn Therapeutics, Inc. | Thyromimetics |
| EP4333844A4 (en) * | 2021-05-06 | 2025-03-19 | Autobahn Therapeutics, Inc. | Fatty acid amide hydroase (FAAH)-cleavable prodrugs of thyromimetics and combination with peripherally restricted FAAH inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5883294A (en) | 1997-06-18 | 1999-03-16 | The Regeants Of The University Of California | Selective thyroid hormone analogs |
| US6436990B1 (en) * | 1999-10-27 | 2002-08-20 | Nobex Corporation | 6-methoxy-2-naphthylacetic acid prodrugs |
| US6429223B1 (en) * | 2000-06-23 | 2002-08-06 | Medinox, Inc. | Modified forms of pharmacologically active agents and uses therefor |
| WO2006128056A2 (en) | 2005-05-26 | 2006-11-30 | Metabasis Therapeutics, Inc. | Novel phosphinic acid-containing thyromimetics |
| MX2007014502A (es) * | 2005-05-26 | 2008-02-07 | Metabasis Therapeutics Inc | Tiromimeticos para el tratamiento de enfermedades del higado graso. |
| PE20180021A1 (es) | 2015-02-20 | 2018-01-09 | Univ Oregon Health & Science | Derivados de sobetiroma |
| WO2017015360A1 (en) | 2015-07-20 | 2017-01-26 | Oregon Health & Science University | Quinolone-3-diarylethers |
| DK3457851T3 (da) * | 2016-05-18 | 2021-09-20 | Univ Oregon Health & Science | Derivater af sobetirom |
| US11325886B2 (en) * | 2016-08-12 | 2022-05-10 | Oregon Health & Science University | Amide compounds, pharmaceutical compositions thereof, and methods of using the same |
-
2019
- 2019-02-13 US US16/969,793 patent/US11578032B2/en active Active
- 2019-02-13 BR BR112020016599-9A patent/BR112020016599A2/pt unknown
- 2019-02-13 MX MX2020008498A patent/MX2020008498A/es unknown
- 2019-02-13 EP EP19754827.4A patent/EP3752001A4/en active Pending
- 2019-02-13 KR KR1020207025750A patent/KR20200120928A/ko not_active Ceased
- 2019-02-13 CA CA3091021A patent/CA3091021A1/en active Pending
- 2019-02-13 IL IL276592A patent/IL276592B2/en unknown
- 2019-02-13 JP JP2020543286A patent/JP2021513547A/ja active Pending
- 2019-02-13 AU AU2019222709A patent/AU2019222709A1/en not_active Abandoned
- 2019-02-13 WO PCT/US2019/017881 patent/WO2019160980A1/en not_active Ceased
- 2019-02-13 CN CN201980015169.5A patent/CN111818798A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021513547A5 (enExample) | ||
| JP2024514703A5 (enExample) | ||
| JP2020023528A5 (enExample) | ||
| JP2017537940A5 (enExample) | ||
| JP2021191784A5 (enExample) | ||
| JP2018070614A5 (enExample) | ||
| JP2022513449A5 (enExample) | ||
| MX2022006470A (es) | Tiromimeticos novedosos. | |
| JP2003530432A5 (enExample) | ||
| CA2563743A1 (en) | New pharmaceutical compositions for the treatment of sexual disorders ii | |
| JP2014528464A5 (enExample) | ||
| JP2019520344A5 (enExample) | ||
| JP2009536620A5 (enExample) | ||
| JP2006501295A5 (enExample) | ||
| JP2019516739A5 (enExample) | ||
| JP2021528488A5 (enExample) | ||
| JP2018507886A5 (enExample) | ||
| JP2017505293A5 (enExample) | ||
| RU2010107169A (ru) | Фармацевтическая композиция, содержащая оптически активное соединение, обладающее активностью агониста рецептора тромбопоэтина, и промежуточное соединение для этого | |
| JPWO2023195529A5 (enExample) | ||
| JP2022512736A5 (enExample) | ||
| JP2020511536A5 (enExample) | ||
| JP2022508513A5 (enExample) | ||
| AR029412A1 (es) | Forma cristalina | |
| JP2025142197A5 (enExample) |